4D MEDICINE LTD
- 72110Research and experimental development on biotechnology
- 72190Other research and experimental development on natural sciences and engineering
Opportunity 76/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (65/100).
Data confidence
Overall: high (80/100)Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2024-09-30 | 2023-09-30 |
|---|---|---|
| Total assets | £1.67M | — |
| Current assets | £1.73M | — |
| Cash | £1.66M | — |
| Debtors | £70.1k | — |
| Net assets | £1.67M | — |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 capital
- • 1 miscellaneous
- • 3 capital
- • 1 miscellaneous
Corporate timeline (31 events)Click to expand
- 2026-04-02📄capital-allotment-sharescapital · SH01
- 2026-03-10📄legacymiscellaneous · RP01SH01
- 2025-12-22📄capital-allotment-sharescapital · SH01
- 2025-12-22📄capital-allotment-sharescapital · SH01
- 2025-06-23📄capital-allotment-sharescapital · SH01
- 2025-05-31📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-04-17📄capital-allotment-sharescapital · SH01
- 2025-04-14📄resolutionresolution · RESOLUTIONS
- 2025-04-03📄capital-allotment-sharescapital · SH01
- 2025-03-04📄appoint-person-director-company-with-name-dateofficers · AP01
- 2025-02-28➕COWLING, Didier Shaun Philip appointeddirector
- 2024-04-25📄memorandum-articlesincorporation · MA
- 2024-04-25📄resolutionresolution · RESOLUTIONS
- 2024-04-18📄appoint-person-director-company-with-name-dateofficers · AP01
- 2024-04-17➕BUCKLAND, Thomas, Dr appointeddirector
- 2024-01-25📄capital-allotment-sharescapital · SH01
- 2023-12-15📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-12-15📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2023-11-03📄termination-director-company-with-name-termination-dateofficers · TM01
- 2023-11-02➖DEVINE, John, Dr resigneddirector
- 2023-09-28📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2022-12-22📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-07-27📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-02-18📄memorandum-articlesincorporation · MA
- 2021-10-25➕REEVES, Philip Edward, Dr appointeddirector
- 2021-07-08➕DEVINE, John, Dr appointeddirector
- 2020-03-10➕SMITH, Philip Norman appointeddirector
- 2020-03-10➖WEEMS, Andrew Christopher, Dr resigneddirector
- 2018-10-01🏢Company incorporatedAs 4D MEDICINE LTD
- 2018-10-01➕DOVE, Andrew Peter, Dr appointeddirector
- 2018-10-01➕WEEMS, Andrew Christopher, Dr appointeddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- -5 active directors: Broader management team in place — suggests transferable governance.
- +Founder age: Director aged approximately 65 — succession pressure is live.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primaryFounder aged 63+: Senior director is approximately 65. Approaching typical UK retirement age — succession thinking likely.
Red flags
cleanRadial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Manufacturing · NG postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 11803074 LIMITED→ 11803074 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| 17D LIMITED→ 11776389 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| 1ST CALL REFRIGERATION LTD→ 10155638 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
| 1ST FABS LTD→ 14237521 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| 2 SURFACE LEATHER LTD→ 08254727 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| 4D BDORMANT LTD→ 12409059 · est 2020 · no financials extracted | — | — | — | — | 6y | — | — |
| 4D MEDICAL DEVICES LTD→ 14999593 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| 5 BOROUGHS LUBRICANTS LTD.→ 08931515 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
| 8 STAGE LIMITED→ 05955295 · est 2006 · no financials extracted | — | — | — | — | 19y | — | — |
| A.B. CONVEYORS LTD→ 09854541 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| A1 GARDEN BUILDINGS LIMITED→ 04320360 · est 2001 · no financials extracted | — | — | — | — | 24y | — | — |
| A1 SECURE FABRICATIONS LTD→ 08911395 · est 2014 · no financials extracted | — | — | — | — | 12y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (5 active · 2 resigned)
Click a director name to see their full track record across all companies.